VAERS 2714369
GLAXOSMITHKLINE BIOLOGICALS · DTAP + IPV (KINRIX) · Charge 3UMFG
- Staat
- MI
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 16.11.2023
- Impfdatum
- 03.11.2023
- Beginn
- 03.11.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Symptomtext
2 years and a half old, received Kinrix; 2 years and a half old, received Kinrix; This non-serious case was reported by a physician via call center representative and described the occurrence of inappropriate age at vaccine administration in a 30-month-old male patient who received DTPa-IPV (Kinrix) (batch number 3UMFG, expiry date 13-FEB-2026) for prophylaxis. On 03-NOV-2023, the patient received Kinrix. On 03-NOV-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 2 years and a half old, received Kinrix) and inappropriate schedule of vaccine administered (Verbatim: 2 years and a half old, received Kinrix). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 06-NOV-2023 The physician reported that the 2 years and half old patient received Kinrix. This was the 3rd Dtap dose in the series. The vaccine administration facility was the same as primary reporter. The patient received a dose of Kinrix at an age of 2 years and a half old and it was the 3rd Dtap dose in the series, which led to inappropriate age at vaccine administration and Inappropriate schedule of vaccine administered. The reporter did not consent to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -